NCT04609462View on ClinicalTrials.gov

High-Flow Nasal Cannula in Severe COVID-19 With Acute Hypoxemic Respiratory Failure.

NACompletedINTERVENTIONAL
Enrollment

199

Participants

Timeline

Start Date

August 11, 2020

Primary Completion Date

January 13, 2021

Study Completion Date

February 10, 2021

Conditions
Covid19Acute Hypoxemic Respiratory Failure
Interventions
PROCEDURE

Conventional oxygen therapy

Oxygen therapy by conventional nasal cannula / prongs, venturi mask, or mask with reservoir

PROCEDURE

High flow nasal cannula

Breathing support with High-flow nasal cannula

Trial Locations (1)

76032

Fundacion Valle del Lili, Santiago de Cali

All Listed Sponsors
lead

Fundacion Clinica Valle del Lili

OTHER

NCT04609462 - High-Flow Nasal Cannula in Severe COVID-19 With Acute Hypoxemic Respiratory Failure. | Biotech Hunter | Biotech Hunter